Yayın:
Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurhal, N. S.
dc.contributor.authorHasan Şenol Çoşkun
dc.contributor.authorFaysal Dane
dc.contributor.authorBülent Karabulut
dc.contributor.authorMustafa Karaağaç
dc.contributor.authorDevrim Çabuk
dc.contributor.authorSenem Karabulut
dc.contributor.authorNuri Faruk Aykan
dc.contributor.authorHatice Doruk
dc.contributor.authorNilüfer Avcı
dc.contributor.authorN. S. Turhal
dc.contributor.authorMehmet Artaç
dc.contributor.orcid0000-0001-6931-6896
dc.contributor.orcid0000-0003-2969-7561
dc.contributor.orcid0000-0001-6584-902X
dc.contributor.orcid0000-0002-1949-8334
dc.contributor.orcid0000-0003-4533-0620
dc.contributor.orcid0000-0002-7871-6311
dc.contributor.orcid0000-0003-4740-9973
dc.contributor.orcid0000-0002-5472-3218
dc.contributor.orcid0000-0002-1013-5676
dc.contributor.orcid0000-0003-2335-3354
dc.date.accessioned2025-11-13T10:48:04Z
dc.date.issued2018-05-30
dc.identifier.doihttps://doi.org/10.1016/j.suronc.2018.05.032
dc.identifier.endpage489
dc.identifier.issn0960-7404
dc.identifier.issue3
dc.identifier.openalexW2807670400
dc.identifier.startpage485
dc.identifier.urihttps://hdl.handle.net/11421/5295
dc.identifier.urihttps://doi.org/10.1016/j.suronc.2018.05.032
dc.identifier.volume27
dc.language.isoen
dc.relation.ispartofSurgical Oncology
dc.rightsrestrictedAccess
dc.subjectMedicine
dc.subjectKRAS
dc.subjectBevacizumab
dc.subjectColorectal cancer
dc.subjectInternal medicine
dc.subjectOncology
dc.subjectSurgery
dc.subjectPrimary tumor
dc.subjectChemotherapy
dc.subjectCancer
dc.subjectMetastasis
dc.subject.sdg3
dc.titleKras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5064011743

Dosyalar

Koleksiyonlar

Publications